• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

324株非发酵革兰阴性杆菌对6种头孢菌素及氨曲南的敏感性

Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.

作者信息

Appelbaum P C, Tamim J, Pankuch G A, Aber R C

出版信息

Chemotherapy. 1983;29(5):337-44. doi: 10.1159/000238217.

DOI:10.1159/000238217
PMID:6311492
Abstract

Susceptibility of 324 isolates of nonfermentative gram-negative bacteria to cephalothin, cefamandole, cefoxitin, ceftazidime, cefsulodin, and azthreonam was determined by agar dilution and disc diffusion techniques. With the exception of Moraxella species, first- and second-generation cephalosporins were minimally active against nonfermenters tested. Cefsulodin and azthreonam were mainly active against Pseudomonas aeruginosa. In contrast, ceftazidime and ceftriaxone exhibited wider activity spectra. Cefsulodin and ceftazidime were the most active against P. aeruginosa, followed by azthreonam and ceftriaxone. Ceftazidime was the only drug with significant activity against Pseudomonas maltophilia and Pseudomonas fluorescens/Pseudomonas putida, and was also the most active against Pseudomonas cepacia. Acinetobacter calcoaceticus and Alcaligenes strains were most sensitive to ceftazidime, followed by ceftriaxone and azthreonam. Ceftriaxone was the most active against moraxellas, followed by cefamandole/cefoxitin, ceftazidime, cephalothin, cefsulodin, and azthreonam. Ceftazidime was the most active against uncommonly isolated nonfermenters. Results observed in this study reflect a potential use for ceftazidime in therapy of infections caused by most gram-negative nonfermenters; therapy with cefsulodin and azthreonam in nonfermenter infections should be restricted to those caused by P. aeruginosa, and that with ceftriaxone reserved for non-P. aeruginosa infections.

摘要

采用琼脂稀释法和纸片扩散法测定了324株非发酵革兰阴性菌对头孢噻吩、头孢孟多、头孢西丁、头孢他啶、头孢磺啶和氨曲南的敏感性。除莫拉菌属外,第一代和第二代头孢菌素对所检测的非发酵菌活性极低。头孢磺啶和氨曲南主要对铜绿假单胞菌有活性。相比之下,头孢他啶和头孢曲松的抗菌谱更广。头孢磺啶和头孢他啶对铜绿假单胞菌活性最强,其次是氨曲南和头孢曲松。头孢他啶是唯一对嗜麦芽窄食单胞菌和荧光假单胞菌/恶臭假单胞菌有显著活性的药物,对洋葱伯克霍尔德菌的活性也最强。醋酸钙不动杆菌和产碱杆菌菌株对头孢他啶最敏感,其次是头孢曲松和氨曲南。头孢曲松对莫拉菌属活性最强,其次是头孢孟多/头孢西丁、头孢他啶、头孢噻吩、头孢磺啶和氨曲南。头孢他啶对罕见分离的非发酵菌活性最强。本研究结果表明,头孢他啶在治疗大多数革兰阴性非发酵菌引起的感染中具有潜在用途;头孢磺啶和氨曲南用于非发酵菌感染的治疗应仅限于由铜绿假单胞菌引起的感染,而头孢曲松则应保留用于非铜绿假单胞菌感染。

相似文献

1
Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.324株非发酵革兰阴性杆菌对6种头孢菌素及氨曲南的敏感性
Chemotherapy. 1983;29(5):337-44. doi: 10.1159/000238217.
2
In vitro activity of ceftazidime and ceftriaxone.头孢他啶和头孢曲松的体外活性。
Clin Ther. 1983;5(6):603-16.
3
[Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].5种β-内酰胺类抗生素(头孢哌酮、头孢磺啶、头孢他啶、氨曲南、N-甲酰亚胺硫霉素)对90株对替卡西林耐药程度各异的铜绿假单胞菌的体外比较活性
Pathol Biol (Paris). 1984 May;32(5):404-7.
4
The activity of ceftazidime compared with those of aztreonam, newer cephalosporins and Sch 29482 against nonfermentative gram-negative bacilli.头孢他啶与氨曲南、新型头孢菌素及Sch 29482相比,对非发酵革兰氏阴性杆菌的活性。
Chemotherapy. 1985;31(3):181-90. doi: 10.1159/000238334.
5
Comparative in vitro activity of first, second and third generation cephalosporins.第一代、第二代和第三代头孢菌素的体外活性比较
Acta Pathol Microbiol Scand B. 1981 Aug;89(4):221-5. doi: 10.1111/j.1699-0463.1981.tb00180_89b.x.
6
Azthreonam activity against gram-negative bacilli.
Chemotherapy. 1984;30(1):44-8. doi: 10.1159/000238244.
7
[In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].头孢曲松对具有不同头孢菌素耐药表型的革兰阴性杆菌的体外活性。与头孢噻肟、头孢甲肟、拉氧头孢、头孢他啶的比较
Pathol Biol (Paris). 1986 May;34(5):404-9.
8
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.八种β-内酰胺酶稳定型头孢菌素对产β-内酰胺酶革兰氏阴性杆菌的体外活性比较
Antimicrob Agents Chemother. 1981 Mar;19(3):407-13. doi: 10.1128/AAC.19.3.407.
9
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].[头孢甲肟(SCE 1365)对616株因对β-内酰胺耐药而挑选出的医院革兰氏阴性杆菌的体外活性。与头孢噻肟、拉氧头孢和头孢他啶的比较]
Pathol Biol (Paris). 1983 May;31(5):351-6.
10
[Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
G Batteriol Virol Immunol. 1983 Jul-Dec;76(7-12):246-56.

引用本文的文献

1
Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method.通过阻抗法对阳性血培养物中发酵型与非发酵型革兰氏阴性杆菌进行快速鉴别。
J Clin Microbiol. 2000 Oct;38(10):3589-94. doi: 10.1128/JCM.38.10.3589-3594.2000.
2
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.通过棋盘法和时间杀菌研究测定左氧氟沙星、氧氟沙星和环丙沙星单独及与阿米卡星联合使用时对不动杆菌的活性。
Antimicrob Agents Chemother. 1997 May;41(5):1073-6. doi: 10.1128/AAC.41.5.1073.
3
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
通过琼脂稀释法和E-test MIC法测定β-内酰胺类药物对不动杆菌属菌种的活性。
Antimicrob Agents Chemother. 1997 Apr;41(4):767-70. doi: 10.1128/AAC.41.4.767.
4
Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.再看甲氧苄啶-磺胺甲恶唑:其在肠外治疗中的作用。
Eur J Clin Microbiol. 1984 Jun;3(3):174-6. doi: 10.1007/BF02014872.
5
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
6
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.氨曲南。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002.
7
The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.囊性纤维化患者中洋葱伯克霍尔德菌的流行病学。
Eur J Epidemiol. 1987 Dec;3(4):336-42. doi: 10.1007/BF00145642.
8
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.头孢曲松。对其抗菌活性和药代动力学特性的重新评估,以及关于其治疗用途的最新情况,特别提及每日一次给药。
Drugs. 1988 Jun;35(6):604-45. doi: 10.2165/00003495-198835060-00002.
9
Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates.禽博德特氏菌和支气管败血博德特氏菌分离株的抗菌药敏性
Antimicrob Agents Chemother. 1989 May;33(5):771-2. doi: 10.1128/AAC.33.5.771.
10
Human infections associated with Bordetella bronchiseptica.与支气管败血波氏杆菌相关的人类感染。
Clin Microbiol Rev. 1991 Jul;4(3):243-55. doi: 10.1128/CMR.4.3.243.